These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9743291)

  • 1. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.
    Obwegeser A; Jakober R; Kostron H
    Br J Cancer; 1998 Sep; 78(6):733-8. PubMed ID: 9743291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral vs systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model.
    Mannino S; Molinari A; Sabatino G; Ciafrè SA; Colone M; Maira G; Anile C; Arancia G; Mangiola A
    Int J Immunopathol Pharmacol; 2008; 21(1):227-31. PubMed ID: 18336750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDT effects of m-THPC and ALA, phototoxicity and apoptosis.
    Bourré L; Rousset N; Thibaut S; Eléouet S; Lajat Y; Patrice T
    Apoptosis; 2002 Jun; 7(3):221-30. PubMed ID: 11997666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain.
    Hebeda KM; Saarnak AE; Olivo M; Sterenborg HJ; Wolbers JG
    Acta Neurochir (Wien); 1998; 140(5):503-12; discussion 512-3. PubMed ID: 9728253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.
    Jones HJ; Vernon DI; Brown SB
    Br J Cancer; 2003 Jul; 89(2):398-404. PubMed ID: 12865935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma.
    Westerman P; Glanzmann T; Andrejevic S; Braichotte DR; Forrer M; Wagnieres GA; Monnier P; van den Bergh H; Mach JP; Folli S
    Int J Cancer; 1998 Jun; 76(6):842-50. PubMed ID: 9626351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat.
    Desroches MC; Bautista-Sanchez A; Lamotte C; Labeque B; Auchère D; Farinotti R; Maillard P; Grierson DS; Prognon P; Kasselouri A
    J Photochem Photobiol B; 2006 Oct; 85(1):56-64. PubMed ID: 16765603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats.
    Olivier D; Bourré L; El-Sabbagh E; Loussouarn D; Simonneaux G; Valette F; Patrice T
    Surg Neurol; 2007 Sep; 68(3):255-63; discussion 263. PubMed ID: 17544487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy.
    Molinari A; Bombelli C; Mannino S; Stringaro A; Toccacieli L; Calcabrini A; Colone M; Mangiola A; Maira G; Luciani P; Mancini G; Arancia G
    Int J Cancer; 2007 Sep; 121(5):1149-55. PubMed ID: 17471562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of alkaline Comet assay to assess DNA repair after m-THPC-PDT.
    Rousset N; Keminon E; Eléouet S; Le Néel T; Auget JL; Vonarx V; Carré J; Lajat Y; Patrice T
    J Photochem Photobiol B; 2000 Jul; 56(2-3):118-31. PubMed ID: 11079472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
    Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
    J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport and localisation of m-THPC in vitro.
    Kessel D
    Int J Clin Pract; 1999 Jun; 53(4):263-7. PubMed ID: 10563069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice.
    Morlet L; Vonarx-Coinsmann V; Lenz P; Foultier MT; de Brito LX; Stewart C; Patrice T
    J Photochem Photobiol B; 1995 Apr; 28(1):25-32. PubMed ID: 7791003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does tumour uptake of Foscan determine PDT efficacy?
    Veenhuizen R; Oppelaar H; Ruevekamp M; Schellens J; Dalesio O; Stewart F
    Int J Cancer; 1997 Oct; 73(2):236-9. PubMed ID: 9335449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foscan-mediated photodynamic therapy for a peritoneal-cancer model: drug distribution and efficacy studies.
    Veenhuizen RB; Ruevekamp MC; Oppelaar H; Helmerhorst TJ; Kenemans P; Stewart FA
    Int J Cancer; 1997 Oct; 73(2):230-5. PubMed ID: 9335448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials.
    Abdulrehman G; Xv K; Li Y; Kang L
    Lasers Med Sci; 2018 Sep; 33(7):1581-1590. PubMed ID: 29796953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
    Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F
    Anticancer Drugs; 2000 Feb; 11(2):85-91. PubMed ID: 10789590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
    van Geel IP; Oppelaar H; Oussoren YG; Schuitmaker JJ; Stewart FA
    Br J Cancer; 1995 Aug; 72(2):344-50. PubMed ID: 7640216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.